RESUMEN
Sodium-ion batteries (SIBs) as a replaceable energy storage technology have attracted extensive attention in recent years. The design and preparation of advanced anode materials with high capacity and excellent cycling performance for SIBs still face enormous challenges. Herein, a solution method is developed for in situ synthesis of anti-aggregation tellurium nanorods/reduced graphene oxide (Te NR/rGO) composite. The material working as the sodium-ion battery (SIB) anode achieves a high reversible capacity of 338 mAh g-1 at 5 A g-1 and exhibits up to 93.4% capacity retention after 500 cycles. This work demonstrates an effective preparation method of nano-Te-based composites for SIBs.
RESUMEN
Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease that progresses to fibrosis and cirrhosis, resulting from the gradual destruction of intrahepatic bile ducts. Exploring genetic variants associated with PBC is essential to understand the pathogenesis of PBC. Here we identify a zebrafish balloon dog (blg) mutant with intrahepatic bile duct branching defects, exhibiting several key pathological PBC-like features, including immunodominant autoantigen PDC-E2 production, cholangiocyte apoptosis, immune cell infiltration, inflammatory activation, and liver fibrosis. blg encodes the protein phosphatase 1 regulatory subunit 21 (Ppp1r21), which is enriched in the liver and its peripheral tissues and plays a vital role in the early intrahepatic bile duct formation stage. Further studies show an excessive activation of the PI3K/AKT/mTOR pathway in the hepatic tissues in the mutant, while treatment with the pathway inhibitor LY294002 and rapamycin partially rescues intrahepatic bile duct branching defects and alleviates the PBC-like symptoms. These findings implicate the potential role of the Ppp1r21-mediated PI3K/AKT/mTOR pathway in the pathophysiology of PBC.
